Form 8-K Neos Therapeutics, Inc. For: Dec 20StreetInsider.comOn December 20, 2016, Neos Therapeutics, Inc. issued a press release entitled “Neos Therapeutics Completes Resubmission of NDA for Cotempla XR-ODT for the Treatment of ADHD” (the “Press Release”).